过去一年中添加的文章，按日期排序
您的搜索 - Editorial comment on: Low-activity V89L variant in SRD5A2 is associated with aggressive prostate cancer risk: an explanation for the adverse effects observed in chemoprevention trials using 5-alpha-reductase inhibitors. - 与所有文章均不相符。
建议：
建议：